---
document_datetime: 2026-01-12 12:15:41
document_pages: 3
document_pathfilename: www.ema.europa.eu/en/documents/procedural-steps-after/abilify-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf
document_name: abilify-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf
version: success
processing_time: 2.4248486
conversion_datetime: 2026-01-14 08:33:00.249624
docling_version:
  docling-serve: 1.10.0
  docling-jobkit: 1.8.1
  docling: 2.68.0
  docling-core: 2.59.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
## Abilify

Procedural steps taken and scientific information after the authorisation*

*Due to the Agency`s update of its procedure management systems, an additional document, reflecting the historical lifecycle may be available in the 'Assessment history' section. For the complete product lifecycle procedures, you may need to also refer to EPAR - Procedural steps taken and scientific information after authorisation (archive) .

| Application number   | Scope                              | Opinion/ Notification 1 issued on   | Commission Decision Issued 2 / amended on   | Product Information affected 3   | Summary                                           |
|----------------------|------------------------------------|-------------------------------------|---------------------------------------------|----------------------------------|---------------------------------------------------|
| Variation type IB /  | C.I HUMAN AND VETERINARY MEDICINAL | 09/01/2026                          |                                             | SmPC and PL                      | To update the term 'pathological gambling' to the |

<!-- image -->

<!-- image -->

<div style=\"page-break-after: always\"></div>

| EMA/VR/0000313289                     | PRODUCTS - C.I.z Other variation - Accepted C.I.z (Type IB) - To update the term 'pathological gambling' to the current MedDRA term 'gambling disorder' throughout the PI and amend the wording on ketoconazole in the PL to reflect that oral ketoconazole is no longer authorised in the EU for the treatment of fungal infections. In addition, the MAH took the opportunity to implement editorial changes, which included updating the list of local representatives in the PL by removing the UK(NI) in line with the Windsor Framework and the QRD template, updating the contact details for the BE and LU local representatives, making minor corrections for the DA and IS local representatives, aligning the PI with the QRD template, and correcting typographical errors. Furthermore, the MAH has taken this opportunity to make corrections to the   |            |     | current MedDRA term 'gambling disorder' throughout the PI and amend the wording on ketoconazole in the PL to reflect that oral ketoconazole is no longer authorised in the EU for the treatment of fungal infections. In addition, the MAH took the opportunity to implement editorial changes, which included updating the list of local representatives in the PL by removing the UK(NI) in line with the Windsor Framework and the QRD template, updating the contact details for the BE and LU local representatives, making minor corrections for the DA and IS local representatives, aligning the PI with the QRD template, and correcting typographical errors. Furthermore, the MAH has taken this opportunity to make corrections to the translated product information.   |
|---------------------------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Variation type IB / EMA/VR/0000290773 | B.II.b.3 Change in the manufacturing process of the finished product, including an intermediate used in the manufacture of the finished product - B.II.b.3.z Other changes - Accepted                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                | 29/08/2025 | N/A |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
| Variation type IA / EMA/VR/0000281420 | This was an application for a group of variations.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   | 22/07/2025 | N/A |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |

<div style=\"page-break-after: always\"></div>

|                                       | A. ADMINISTRATIVE CHANGES - A.7 Deletion of manufacturing sites for an active substance, intermediate or finished product, packaging site, manufacturer responsible for batch release, site where batch control takes place, or supplier of a starting material, reagent or excipient (when mentioned in the dossier)* - Accepted B.II.e.6 Change in any part of the (primary) packaging material not in contact with the finished product formulation (such as colour of flip-off caps, colour code rings on ampoules, change of needle shield (different plastic used)) - B.II.e.6.b Change that does not affect the product information - Accepted   |            |     |
|---------------------------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|
| Variation type IB / EMA/VR/0000279352 | B.II.b.3 Change in the manufacturing process of the finished product, including an intermediate used in the manufacture of the finished product - B.II.b.3.z Other changes - Accepted                                                                                                                                                                                                                                                                                                                                                                                                                                                                   | 15/07/2025 | N/A |